doDOC Corporation

doDOC Corporation is a technology firm specializing in innovative medical affairs solutions, particularly through its collaborative document editing platform designed for the pharmaceutical industry. Founded in 2015 in Boston, US, doDOC Corporation provides advanced tools for managing pharmaceutical document processes. The firm has made 5 deals to date. The CEO and Founder is Federico Cismondi, who has an extensive background in healthcare technology.

In its most recent funding round, the Seed round raised USD 1. 5 mn from Palm Drive Capital, which is the total amount raised to date. doDOC Corporation offers a suite of medical affairs solutions aimed at improving efficiency and compliance throughout the pharmaceutical product life cycle. Central to its offerings is the iEnvision platform, a Software-as-a-Service (SaaS) solution that facilitates evidence generation, grant management, and communication activities.

Key products include doDOC, a collaborative editor for scientific document writing, Datavision for publication planning, iEnvision ISR for managing investigator-sponsored research, and iEnvision ME for medical education grants, serving clients primarily in North America, Europe, and Asia-Pacific. doDOC Corporation generates revenue through a subscription model, where clients pay for access to its platform and services, including doDOC and Datavision. These subscriptions are typically structured as annual contracts, ensuring clients have ongoing access to updates and features. The transactions are mainly B2B, focusing on pharmaceutical companies and healthcare organizations, with pricing tailored to each client's specific needs.

doDOC Corporation plans to expand its product offerings with new features scheduled for release in the coming year, aimed at enhancing user experience and operational efficiency. The company is also targeting growth in new markets, particularly in Europe and Asia, with initiatives set to begin within the next 18 months. The recent Seed funding of USD 1. 5 mn will support these strategic initiatives, facilitating product development and market entry efforts.